Genetic and Metabolic Determinants of Plasma PCSK9 Levels

Seidah, 2003, The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation., Proc Natl Acad Sci USA, 100, 928, 10.1073/pnas.0335507100

Cohen, 2005, Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9., Nat Genet, 37, 161, 10.1038/ng1509

Kotowski, 2006, A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol., Am J Hum Genet, 78, 410, 10.1086/500615

Abifadel, 2003, Mutations in PCSK9 cause autosomal dominant hypercholesterolemia., Nat Genet, 34, 154, 10.1038/ng1161

Cohen, 2006, Sequence variations in PCSK9, low LDL, and protection against coronary heart disease., N Engl J Med, 354, 1264, 10.1056/NEJMoa054013

Brown, 1986, A receptor-mediated pathway for cholesterol homeostasis., Science, 232, 34, 10.1126/science.3513311

Horton, 2007, Molecular biology of PCSK9: its role in LDL metabolism., Trends Biochem Sci, 32, 71, 10.1016/j.tibs.2006.12.008

Zaid, 2008, Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration., Hepatology, 48, 646, 10.1002/hep.22354

Lagace, 2006, Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice., J Clin Invest, 116, 2995, 10.1172/JCI29383

Alborn, 2007, Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol., Clin Chem, 53, 1814, 10.1373/clinchem.2007.091280

Lambert, 2008, Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment., Clin Chem, 54, 1038, 10.1373/clinchem.2007.099747

Mayne, 2008, Plasma PCSK9 levels are significantly modified by statins and fibrates in humans, Lipids Health Dis, 7, 22, 10.1186/1476-511X-7-22

Victor, 2004, The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health., Am J Cardiol, 93, 1473, 10.1016/j.amjcard.2004.02.058

Frank-Kamenetsky, 2008, Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates., Proc Natl Acad Sci USA, 105, 11915, 10.1073/pnas.0805434105

Zhao, 2006, Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote., Am J Hum Genet, 79, 514, 10.1086/507488

Chang, 2007, Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study., J Am Coll Cardiol, 49, 109, 10.1016/j.jacc.2006.10.040

Careskey, 2008, Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9., J Lipid Res, 49, 394, 10.1194/jlr.M700437-JLR200

Boerwinkle, 1988, Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism., Am J Hum Genet, 42, 104

Dubuc, 2004, Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia., Arterioscler Thromb Vasc Biol, 24, 1454, 10.1161/01.ATV.0000134621.14315.43

Rashid, 2005, Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9., Proc Natl Acad Sci USA, 102, 5374, 10.1073/pnas.0501652102

Mayne, 2007, Plasma PCSK9 levels correlate with cholesterol in men but not in women., Biochem Biophys Res Commun, 361, 451, 10.1016/j.bbrc.2007.07.029

Horton, 2003, Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes., Proc Natl Acad Sci USA, 100, 12027, 10.1073/pnas.1534923100

Grefhorst, 2008, Plasma PCSK9 preferentially reduces liver LDL receptors in mice., J Lipid Res, 49, 1303, 10.1194/jlr.M800027-JLR200

Luo, 6 2008, Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice., J Lipid Res, in press

Costet, 2006, Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c., J Biol Chem, 281, 6211, 10.1074/jbc.M508582200

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity., Hepatology, 40, 1387, 10.1002/hep.20466